Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer - Scorecard - MDSpire

Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer

  • By

  • Camille Yongue

  • Ammar Asban

  • Ashley McCormack

  • Caroline A. Snyder

  • Isabella Ferraro

  • Nikolaos Pachos

  • Michael Zervos

  • Robert Cerfolio

  • May 20, 2026

  • 0 min

Share

Clinical Scorecard: Results of Robotic Lung Resection Following Neoadjuvant Treatment in Patients with Non-Small Cell Lung Cancer

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with stage IB-IIIA NSCLC who received neoadjuvant therapy.
Care Setting

Key Highlights

  • additional_complications

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • d
      • d
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • i
      • m
      • a
      • g
      • i
      • n
      • g
      • t
      • e
      • c
      • h
      • n
      • i
      • q
      • u
      • e
      • s
      • f
      • o
      • r
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • p
      • o
      • s
      • t
      • -
      • s
      • u
      • r
      • g
      • e
      • r
      • y
      • .

      Risks

        Patient & Prescribing Data

        Clarify specific regimens and their indications.

        Clinical Best Practices

        • evidence

        Related Resources & Content

        Original Source(s)

        Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer

        • by Camille Yongue, Ammar Asban, Ashley McCormack, Caroline A. Snyder, Isabella Ferraro, Nikolaos Pachos, Michael Zervos, Robert Cerfolio

        • May 20, 2026

        Related Content

        FOXA2 in cancer: from fundamental biology to clinical translation

        Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

        Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2